title: Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections.
abstract: Carbapenem-resistant Acinetobacter species are increasingly recognized as major nosocomial pathogens, especially in patients with critical illnesses or in intensive care. The ability of these organisms to accumulate diverse mechanisms of resistance limits the available therapeutic agents, makes the infection difficult to treat, and is associated with a greater risk of death. In this review, we provide an update on the epidemiology, resistance mechanisms, infection control measures, treatment, and outcomes of carbapenem-resistant Acinetobacter infections.
authors.affiliation: Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea.
authors.forename: Uh Jin
authors.initials: UJ
authors.lastname: Kim
authors.affiliation: Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea.
authors.forename: Hee Kyung
authors.initials: HK
authors.lastname: Kim
authors.affiliation: Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea.
authors.forename: Joon Hwan
authors.initials: JH
authors.lastname: An
authors.affiliation: Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea.
authors.forename: Soo Kyung
authors.initials: SK
authors.lastname: Cho
authors.affiliation: Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea.
authors.forename: Kyung-Hwa
authors.initials: KH
authors.lastname: Park
authors.affiliation: Department of Infectious Diseases, Chonnam National University Medical School, Gwangju, Korea.
authors.forename: Hee-Chang
authors.initials: HC
authors.lastname: Jang
keywords: Acinetobacter baumannii; Colistin; Drug therapy